• English
  • Español
    • Home
    • About Us
      • Research Team
      • Self-sustainability Principle
      • Effective Collaboration
    • Research
      • Screening of Microbiota Composition in MS
      • Bacterial Transfer into Gnotobiotic Mice
      • Immunological and Molecular Studies of the Gut-immune System/Brain Axis
      • Clinical Trials
      • Publications
      • SOPs and Supplies
    • Study Participants
      • iMSMS Study Tracker
      • Online Food Questionnaire Instructions
      • Study Progress
      • Instructions for Stool Sample Acquisition
    • Links
    • Contact Us
      • Donate

    Author's Posts

    iMSMS Resumes Participant Recruitment at UCSF

    The COVID-19 pandemic has posed numerous challenges on a global scale. It has undoubtedly impacted our clinical research efforts here at UCSF and all other academic institutions. Both domestically and abroad, many research visits were postponed, suspended or continue...

    November 05, 2020 at 8:37 pm admin read more

    UCSF Leads International Study on the Microbiome and Multiple Sclerosis

    The international MS microbiome study (iMSMS, www.preprod.imsms.temperies.com) may shed light on the role the gut flora plays in MS. Many people are familiar with the concept of gut flora- the bacteria and other organisms that live in the digestive tract...

    June 30, 2016 at 1:22 pm admin read more

    The White House Office of Science and Technology Policy:Announcing the National Microbiome Initiative

    The White House Office of Science and Technology Policy (OSTP), in collaboration with Federal agencies and private-sector stakeholders, is announcing a new National Microbiome Initiative (NMI) to foster the integrated study of microbiomes across different ecosystems

    June 30, 2016 at 1:21 pm admin read more

    Wrapping Up Multiple Sclerosis

    With one drug to shut down its progression and another to undo its damage, plus a worldwide effort stalking the origins of multiple sclerosis, MS doesn’t stand a chance. Multiple sclerosis (MS) usually sets in with neurological symptoms that evolve...

    April 25, 2016 at 1:24 pm admin read more

    Kit Contents

    November 05, 2015 at 6:38 pm admin read more

    Sample Collection

    November 05, 2015 at 6:33 pm admin read more

    Packing

    November 05, 2015 at 6:31 pm admin read more

    Study Videos

    Kit Contents

    Sample Collection

    Packing

    Contact Us

    Boston: (415) 514-2132
    Boston@imsms.org
    Buenos Aires: +54 (11) 5777-3200 int.2704/2708
    BuenosAires@imsms.org
    Edinburgh: +44 0131-465-9517
    Edinburgh@imsms.org
    New York: (212) 241-6854
    NewYork@imsms.org
    Philadelphia: (215) 220-9384
    Philadelphia@imsms.org
    Pittsburgh: (412) 254-4883
    Pittsburgh@imsms.org
    San Diego: (858) 246-2905
    SanDiego@imsms.org
    San Francisco: (415) 502-7197
    SanFrancisco@imsms.org
    San Sebastian: +34 943-007-246
    SanSebastian@imsms.org

    FAQs

    • Do I qualify for the International MS Microbiome Study (iMSMS)?
    • What is this study?
    • What causes multiple sclerosis?
    • How will we do it?
    • Why study bacteria?
    • What can be done with this information?

    Our Mission

    We will investigate the role of gut bacteria (microbiota) and their genes (microbiome) in multiple sclerosis (MS) and use that understanding to design a clinical trial that will represent an entirely new approach to the treatment of multiple sclerosis.

    Copyright © 2020. All Rights reserved.

    Website design courtesy of Temperies